Latest news
Loading news…
Viamet Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Morrisville, North Carolina, United States Founded 2005 11-50 employees For Profit
Viamet discovers and develops small molecule inhibitors via an enzyme binding approach for the treatment of various diseases.
Viamet Pharmaceuticals was acquired by Novaquest Capital Management in 2018.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
- IT spend
- $911.31K
Company Info
- Founded
- 2005
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 31
- HQ
- Morrisville, North Carolina, United States
- Region
- Research Triangle, East Coast, Southern US
- Exit date
- Jan 3, 2018
- Closed
- Jan 1, 2018
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.6
- Trend (90d)
- 0.3
- Last leadership hire
- Mar 3, 2025
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Viamet Pharmaceuticals
Loading news…
FAQs about Viamet Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.